SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-1.63%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$527M
AUM Growth
+$527M
(-12%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-5.61%
Top 10 Holdings %
Top 10 Hldgs %
65.74%
Holding
74
New
14
Increased
17
Reduced
12
Closed
23
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$32.5M |
| 2 |
Eli Lilly
LLY
|
$20.1M |
| 3 |
Nice
NICE
|
$10.7M |
| 4 |
FIVE9
FIVN
|
$10.1M |
| 5 |
Amicus Therapeutics
FOLD
|
$8.09M |
Top Sells
| 1 |
Pfizer
PFE
|
$26.7M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$16.3M |
| 3 |
Kymera Therapeutics
KYMR
|
$15.6M |
| 4 |
ZIM Integrated Shipping Services
ZIM
|
$10.8M |
| 5 |
Generac Holdings
GNRC
|
$8.39M |
Sector Composition
| 1 | Healthcare | 83.89% |
| 2 | Technology | 5.42% |
| 3 | Communication Services | 1.53% |
| 4 | Financials | 0.47% |
| 5 | Consumer Discretionary | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rezolute
RZLT
$630M
| $3.73M | 0.4% |
+1,155,897
| New | +$3.73M |
|
27
VistaGen Therapeutics
VTGN
$113M
| $2.9M | 0.31% |
109,705
-55,342
| -34% | -$1.46M |
|
|
CNCE
28
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.86M | 0.31% |
+679,400
| New | +$2.86M |
|
29
Rigel Pharmaceuticals
RIGL
$710M
| $2.85M | 0.31% |
+252,500
| New | +$2.85M |
|
30
PMV Pharmaceuticals
PMVP
$82.1M
| $2.68M | 0.29% |
+187,800
| New | +$2.68M |
|
31
Visa
V
$681B
| $2.48M | 0.27% |
12,600
-12,600
| -50% | -$2.48M |
|
32
Kezar Life Sciences
KZR
$28.5M
| $2.48M | 0.27% |
29,965
+11,205
| +60% | +$927K |
|
33
Airbnb
ABNB
$76.5B
| $2.47M | 0.26% |
27,700
-2,300
| -8% | -$205K |
|
34
Werewolf Therapeutics
HOWL
$62.6M
| $2.44M | 0.26% |
597,003
+12,800
| +2% | +$52.4K |
|
35
Invesco QQQ Trust
QQQ
$364B
| $2.29M | 0.25% |
+8,186
| New | +$2.29M |
|
36
Keros Therapeutics
KROS
$638M
| $1.88M | 0.2% |
67,997
-71,584
| -51% | -$1.98M |
|
37
NVIDIA
NVDA
$4.15T
| $1.71M | 0.18% |
+112,880
| New | +$1.71M |
|
38
89bio
ETNB
$1.37B
| $1.45M | 0.16% |
+450,000
| New | +$1.45M |
|
|
MGIC
39
Magic Software Enterprises
MGIC
$956M
| $1.45M | 0.15% |
81,293
| – | – |
|
40
Advanced Micro Devices
AMD
$263B
| $1.21M | 0.13% |
15,773
-84,227
| -84% | -$6.44M |
|
|
KNTE
41
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $1.16M | 0.12% |
+91,673
| New | +$1.16M |
|
|
ONCR
42
DELISTED
Oncorus, Inc.
ONCR
| $681K | 0.07% |
540,258
| – | – |
|
|
43
Generac Holdings
GNRC
$10.3B
| $486K | 0.05% |
2,310
-39,901
| -95% | -$8.39M |
|
|
OTMO
44
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
| $431K | 0.05% |
26,124
| – | – |
|
45
Arbe Robotics
ARBE
$136M
| $237K | 0.03% |
43,165
| – | – |
|
|
IMTXW
46
DELISTED
Immatics N.V. Warrants
IMTXW
| $204K | 0.02% |
100,000
| – | – |
|
|
VINC
47
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $93K | 0.01% |
3,523
-32,485
| -90% | -$858K |
|
48
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-24,768
| Closed | -$4.04M |
|
49
Ascendis Pharma
ASND
$12.1B
| – | – |
-26,529
| Closed | -$3.11M |
|
|
50
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-211,326
| Closed | -$16.3M |
|